SA Eckernas

492 total citations
8 papers, 375 citations indexed

About

SA Eckernas is a scholar working on Cellular and Molecular Neuroscience, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, SA Eckernas has authored 8 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 3 papers in Neurology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in SA Eckernas's work include Neuroscience and Neuropharmacology Research (3 papers), Neurological disorders and treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). SA Eckernas is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Neurological disorders and treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). SA Eckernas collaborates with scholars based in Sweden and United States. SA Eckernas's co-authors include A. Grahnén, Bengt Långström, Per Hartvig, H. Lundquist, J. Hägglund, Sten‐Magnus Aquilonius, Per Gullberg, Aquilonius Sm, Bengt Dahlström and Antony D. Gee and has published in prestigious journals such as British Journal of Clinical Pharmacology, Acta Neurologica Scandinavica and Biopharmaceutics & Drug Disposition.

In The Last Decade

SA Eckernas

8 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SA Eckernas Sweden 7 159 116 69 60 59 8 375
S.-�. Eckern�s Sweden 8 58 0.4× 50 0.4× 48 0.7× 27 0.5× 73 1.2× 9 328
Léo Berger Canada 10 100 0.6× 168 1.4× 26 0.4× 80 1.3× 93 1.6× 13 546
Ya-Yao Huang Taiwan 10 129 0.8× 46 0.4× 133 1.9× 84 1.4× 43 0.7× 30 382
M. Guyot France 13 131 0.8× 56 0.5× 29 0.4× 74 1.2× 62 1.1× 25 609
Denis Fournier France 9 148 0.9× 21 0.2× 52 0.8× 98 1.6× 64 1.1× 15 339
S Bongrani Italy 13 63 0.4× 24 0.2× 143 2.1× 23 0.4× 109 1.8× 48 440
Duffy Te 7 110 0.7× 69 0.6× 79 1.1× 45 0.8× 95 1.6× 10 356
D. W. McCandless United States 13 158 1.0× 103 0.9× 67 1.0× 15 0.3× 187 3.2× 25 478
Shingo Ono Japan 13 66 0.4× 28 0.2× 27 0.4× 10 0.2× 53 0.9× 39 494
K Inamura Japan 9 120 0.8× 49 0.4× 53 0.8× 28 0.5× 97 1.6× 33 336

Countries citing papers authored by SA Eckernas

Since Specialization
Citations

This map shows the geographic impact of SA Eckernas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Eckernas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Eckernas more than expected).

Fields of papers citing papers by SA Eckernas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SA Eckernas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Eckernas. The network helps show where SA Eckernas may publish in the future.

Co-authorship network of co-authors of SA Eckernas

This figure shows the co-authorship network connecting the top 25 collaborators of SA Eckernas. A scholar is included among the top collaborators of SA Eckernas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SA Eckernas. SA Eckernas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Askmark, Håkan, Sten‐Magnus Aquilonius, SA Eckernas, P. Fawcett, & Agneta Nordberg. (2009). EFFECTS OF DENERVATION AND REINNERVATION ON ACETYLCHOLINE SYNTHESIZING ACTIVITY AND NICOTINE-LIKE BINDING SITES IN RAT HIND LIMB MUSCLES:. Acta Neurologica Scandinavica. 65(S90). 50–51. 1 indexed citations
2.
Grahnén, A., et al.. (1994). An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers [see comments]. British Journal of Clinical Pharmacology. 38(6). 521–525. 82 indexed citations
3.
Grahnén, A., et al.. (1992). Pharmacokinetics of ketotiffn after oral administration to healthy male subjects. Biopharmaceutics & Drug Disposition. 13(4). 255–262. 29 indexed citations
4.
Alván, Gunnar, Gilles Paintaud, SA Eckernas, & A. Grahnén. (1992). Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.. British Journal of Clinical Pharmacology. 34(1). 47–52. 26 indexed citations
5.
Grahnén, A., et al.. (1991). Inter‐ and intraindividual variability in the concentration‐effect (sedation) relationship of flunitrazepam.. British Journal of Clinical Pharmacology. 31(1). 89–92. 22 indexed citations
6.
Aquilonius, Sten‐Magnus, SA Eckernas, Per Hartvig, et al.. (1987). In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography. Acta Neurologica Scandinavica. 76(4). 283–287. 96 indexed citations
7.
Eckernas, SA, Sten‐Magnus Aquilonius, Per Hartvig, et al.. (1987). Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using11C-N-methyl-spiperone. Acta Neurologica Scandinavica. 75(3). 168–178. 33 indexed citations
8.
Hägglund, J., Aquilonius Sm, SA Eckernas, et al.. (1987). Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using11C-N-methyl-spiperone. Acta Neurologica Scandinavica. 75(2). 87–94. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026